Loading...
Loading...
Clinical protocols and compliance framework for all Quantum Cell Factor variants.
This Standing Order Packet constitutes medical directives and must be used in conjunction with provider clinical judgment, facility policies, and the RegenTherapy Quantum Cheat Sheet. Use is restricted to licensed medical professionals under appropriate clinical oversight and regulatory compliance.
Authorized By
Medical Director / Supervising Provider
Applies To
All Quantum Variants
Review Cycle
Every 90 days
Document Owner
RegenTherapy Clinical Governance
The purpose of this Standing Order Packet is to establish standardized, provider-directed frameworks for the preparation, handling, and administration of Quantum Cell Factor products within the RegenTherapy ecosystem. These standing orders are designed to support consistency, safety, and clinical integrity across multiple care settings while preserving individualized medical decision-making.
This document applies to licensed medical professionals operating under an authorized supervising provider and does not replace clinical judgment, patient evaluation, or informed consent.
Quantum Cell Factor products are biologically inspired signaling formulations intended to support cellular communication, mitochondrial efficiency, inflammatory modulation, and regenerative signaling pathways.
Variants include:
Color selection, sequencing, and escalation strategies are defined in the RegenTherapy Quantum Cheat Sheet.
All patients must undergo appropriate medical screening prior to initiation of Quantum Cell Factor protocols. Final determination of eligibility rests solely with the supervising provider.
Quantum Cell Factor administration must occur under active medical oversight. Standing orders do not constitute blanket approval for use in all patients.
Each Quantum Cell Factor vial is designated for single-use only and is not approved for multi-dose, shared, or repeated use under any circumstances.
Approved routes of administration include Intravenous (IV), Subcutaneous (SQ), Intranasal (IN), and Nebulized.
Dilute reconstituted product in IV-compatible fluid per facility protocol. Administer under licensed supervision with appropriate monitoring.
Administer via subcutaneous injection using standard aseptic technique. Rotate injection sites per best practices.
Administer using an approved intranasal delivery device. Avoid use in patients with active nasal pathology unless cleared by provider.
Administer using a medical-grade nebulizer. Monitor patients during administration. Avoid use in active pulmonary instability unless approved by provider.
Condition-specific protocols, sequencing strategies, cadence, and route selection rationale are maintained within the RegenTherapy Quantum Cheat Sheet.
The Quantum Cheat Sheet functions as a living clinical document and represents the authoritative reference for protocol design. Clinical staff are expected to reference the most current version prior to initiation or modification of therapy.
Patients should be monitored for tolerance and adverse responses during and after administration.
All administrations must be documented in the patient medical record, including:
Quantum Cell Factor products are utilized within a provider-directed longevity and regenerative framework. These standing orders are not intended to diagnose, treat, cure, or prevent disease.
All use must comply with applicable federal, state, and local regulations, facility policies, and professional licensure requirements.
This document is subject to periodic review and revision as protocols evolve. Supersedes all prior versions.
For questions regarding this Standing Order Packet or clinical protocol details, contact RegenTherapy clinical support.
Contact RegenTherapy